Concepedia

Xiaozhong Qian

XQ

Statistics

Publications

29

Citations

3.2K

H-Index

21

Active since

1998

Affiliations

Sepragen Corporation (United States)(Current)

Dana-Farber Cancer Institute

Daiichi Sankyo (United States)

Memorial Sloan Kettering Cancer Center

The University of Texas MD Anderson Cancer Center

Xiaozhong Qian is an author at Sepragen Corporation (United States) specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

1998–2023

29

Publications

29

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

Nagma Khan, Michael Jeffers, Sampath Kumar et al. · Biochemical Journal · 2007 · 710 citations · Full text

, , +10

Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated <i>MGMT</i> promoter: An international randomized phase III trial

Antonio Omuro, Alba A. Brandes, Ahmed Idbaïh et al. · Neuro-Oncology · 2022 · 485 citations · Full text

, , +17

Effects of PS1 Deficiency on Membrane Protein Trafficking in Neurons

Satoshi Naruse, Gopal Thinakaran, Jin Jun Luo et al. · Neuron · 1998 · 358 citations · Full text

, , +17

Identification and Characterization of Novel Substrates of Trk Receptors in Developing Neurons

Xiaozhong Qian, Yuan Zhang, David D. Ginty · Neuron · 1998 · 249 citations · Full text

, , +17

Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition

Andressa S. Laino, David Woods, Melinda Vassallo et al. · Journal for ImmunoTherapy of Cancer · 2020 · 248 citations · Full text

, , +17

1–5 of 29